Insights On Drug Development

  1. Ask Us Anything: Michael Tracey On DoE In Process Characterization 7/24/2026

    Insights into the validation expertise behind process characterization and how deep problem-solving can turn a process into one robust enough to carry a drug to market.

  2. Keeping Future Manufacturing Options Open During Development 7/24/2026

    Early choices affect manufacturing flexibility, tech transfer, and supply chain resilience. Addressing IP and production needs early helps preserve options for commercialization.

  3. Ask Us Anything: Jillian Sheeran On Emerging Reactor Technologies 7/23/2026

    Jillian Sheeran, Associate Director of Engineering at Snapdragon Chemistry, on how automation, feedback control, and machine learning are changing reactor design — with real-time monitoring that lets a process run continuously while the data comes to you.

  4. Ask Us Anything: Mark Benger On Solid-State Strategies For Drug Development 7/23/2026

    Mark Benger, Site Director at Cambrex Edinburgh, on solid-state characterization as an insurance policy — front-loaded work that quietly determines whether a program survives the jump from kilos to tonnes.

  5. Ask Us Anything: Antje Gupta On Biocatalysts In Process Development 7/23/2026

    Antje Gupta, General Manager of Cambrex IEP in Wiesbaden, on where biocatalysis outperforms conventional chemistry — matching enzyme classes to target conversions and production volumes to find the more scalable, more economical route.

  6. Ask Us Anything: Anmaris Torres On The First Steps In Process Transfer 7/23/2026

    Anmaris Torres, Process Engineering Team Leader, on why a process transfer starts with a conversation across departments to figure out how to cut cycle time before commercial production begins.

  7. Ask Us Anything: Daniele Vigo On Cost-Effective Process Development 7/23/2026

    Daniele Vigo, Assistant Director at Cambrex Milan, on getting yield, purity, and scalability right without burning through the budget.

  8. Ask Us Anything: David Ford On AI And Automation Trends 7/23/2026

    David Ford, Senior Director of Chemistry at Snapdragon Chemistry, on the mountain of data behind every process development program — and why AI's real promise is surfacing the right piece of it at the moment a team needs to decide.

  9. Working With Clients To Develop Manufacturing Processes 7/23/2026

    Greg Buenger, Group Leader of Chemical Development at Cambrex Charles City, on what it actually looks like when R&D hands a process to the plant — chemists on the floor for the first batch, advising operators and troubleshooting in real time.

  10. Ask Us Anything: Ingrid Ekman On Using Technology To Optimize R&D 7/23/2026

    Ingrid Ekman, Director of R&D at Cambrex Karlskoga, on why smoother tech transfer starts much earlier than most teams think — with systematic data and design of experiments that map a process's boundaries before it ever reaches commercial scale.